S H Kelkar & Company Reports Record Sales Amid Rising Interest Expenses and Profit Decline
S H Kelkar & Company, a small-cap specialty chemicals firm, reported record net sales and profit after tax for the quarter ending March 2025. Despite rising interest expenses and a decline in profit before tax, the company maintains a low debt-to-equity ratio and has outperformed the BSE 500 index over the past year.
S H Kelkar & Company, a small-cap player in the specialty chemicals industry, has recently undergone an evaluation adjustment reflecting changes in its financial metrics. The company reported its highest net sales for the quarter ending March 2025, reaching Rs 567.38 crore, alongside a peak profit after tax of Rs 43.20 crore and an earnings per share of Rs 7.41. These figures indicate a solid performance in key areas.However, the company also faced challenges, particularly with its interest expenses, which grew by 30.55% to Rs 39.53 crore over the past nine months. Additionally, the profit before tax, excluding other income, fell to Rs 36.03 crore, marking a decline of 17.9% compared to the previous four-quarter average.
Despite these mixed results, S H Kelkar & Company maintains a low debt-to-equity ratio of 0.50 times, suggesting a manageable level of debt. The stock has demonstrated a market-beating performance over the long term, with a return of 16.88% over the past year, outperforming the BSE 500 index in various time frames.
For more insights on S H Kelkar & Company and its financial trends, you can Discover the Latest Mojo Score and Financial Trend Performance - SignUp in less than 2 Minutes and get FREE Premium Access.
{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)
{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)
Related Stock Links
- {{stockdata.stock.stock_name.value}} Analysis
- {{stockdata.stock.stock_name.value}} Technicals
- {{stockdata.stock.stock_name.value}} Quality
- {{stockdata.stock.stock_name.value}} Valuation
- {{stockdata.stock.stock_name.value}} Financial Trend
- {{stockdata.stock.stock_name.value}} Return Analysis
- {{stockdata.stock.stock_name.value}} Price Analysis
- {{stockdata.stock.stock_name.value}} Quarterly Result Analysis
- {{stockdata.stock.stock_name.value}} Half-Yearly Result Analysis
- {{stockdata.stock.stock_name.value}} Nine Monthly Result Analysis
- {{stockdata.stock.stock_name.value}} Annual Results
- {{stockdata.stock.stock_name.value}} Balance Sheet
- {{stockdata.stock.stock_name.value}} Profit & Loss
- {{stockdata.stock.stock_name.value}} Cash Flow
- {{stockdata.stock.stock_name.value}} News
- {{stockdata.stock.stock_name.value}} Announcements
- {{stockdata.stock.stock_name.value}} Share Holding
- {{stockdata.stock.stock_name.value}} Peer Comparison
Our weekly and monthly stock recommendations are here
Loading...
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Target Price
{{sm.target_price }}
({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
₹{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News
Most Read
